{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To reduce acute inflammation To accelerate recovery of motor function and vision Patient has severe functional impairment\n\n*   **Treatment:** Proton Pump Inhibitor (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection while on high-dose steroids\n\n*   **Treatment:** Low Molecular Weight Heparin (LMWH)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** DVT prophylaxis due to reduced mobility and leg weakness\n\n*   **Treatment:** Physiotherapy and Occupational Therapy\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To assist with mobility and rehabilitation To assess safety for discharge or admission requirements\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Requires definitive diagnosis (MS vs NMO vs MOGAD) via MRI and serology results Requires screening for opportunistic infections prior to initiation\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"To reduce acute inflammation\", \"To accelerate recovery of motor function and vision\", \"Patient has severe functional impairment\"]}, {\"treatment\": \"Proton Pump Inhibitor (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection while on high-dose steroids\"]}, {\"treatment\": \"Low Molecular Weight Heparin (LMWH)\", \"timing\": \"Start Now\", \"reasons\": [\"DVT prophylaxis due to reduced mobility and leg weakness\"]}, {\"treatment\": \"Physiotherapy and Occupational Therapy\", \"timing\": \"Start Now\", \"reasons\": [\"To assist with mobility and rehabilitation\", \"To assess safety for discharge or admission requirements\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Requires definitive diagnosis (MS vs NMO vs MOGAD) via MRI and serology results\", \"Requires screening for opportunistic infections prior to initiation\"]}]"
}